Childhood cancers are complex, rare diseases for which only four specific drugs have been approved in the last 40 years versus 200 in adult cancers. Despite this statistic, there are multiple assets in biopharma companies and academic research centers that hold a real potential to cure several types of childhood cancer. We need to do more if we truly want to guarantee a real impact on kids and adolescents affected by cancer.
This is why Oncoheroes was born, an unprecedented approach in the fight against childhood cancer. We are exclusively focused on leading the discovery and development of better drugs for children and adolescents with cancer.
Ricardo Garcia (CEO) and Cesare Spadoni (COO) will be presenting Oncoheroes and answering audience questions during our launching webinar.